Cargando…
Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Becaris Publishing Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288956/ https://www.ncbi.nlm.nih.gov/pubmed/36515083 http://dx.doi.org/10.2217/cer-2022-0192 |
| _version_ | 1785062181059952640 |
|---|---|
| author | Bruce, Ian N Golam, Sarowar Steenkamp, Jason Wang, Pearl Worthington, Evelyn Desta, Barnabas Psachoulia, Konstantina Erhardt, Wilma Tummala, Raj |
| author_facet | Bruce, Ian N Golam, Sarowar Steenkamp, Jason Wang, Pearl Worthington, Evelyn Desta, Barnabas Psachoulia, Konstantina Erhardt, Wilma Tummala, Raj |
| author_sort | Bruce, Ian N |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10288956 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Becaris Publishing Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102889562023-08-11 Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus Bruce, Ian N Golam, Sarowar Steenkamp, Jason Wang, Pearl Worthington, Evelyn Desta, Barnabas Psachoulia, Konstantina Erhardt, Wilma Tummala, Raj J Comp Eff Res Letter in Reply Becaris Publishing Ltd 2022-12-14 /pmc/articles/PMC10288956/ /pubmed/36515083 http://dx.doi.org/10.2217/cer-2022-0192 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Letter in Reply Bruce, Ian N Golam, Sarowar Steenkamp, Jason Wang, Pearl Worthington, Evelyn Desta, Barnabas Psachoulia, Konstantina Erhardt, Wilma Tummala, Raj Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus |
| title | Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus |
| title_full | Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus |
| title_fullStr | Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus |
| title_full_unstemmed | Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus |
| title_short | Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus |
| title_sort | letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus |
| topic | Letter in Reply |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288956/ https://www.ncbi.nlm.nih.gov/pubmed/36515083 http://dx.doi.org/10.2217/cer-2022-0192 |
| work_keys_str_mv | AT bruceiann letterinreplyindirecttreatmentcomparisonofanifrolumabefficacyversusbelimumabinadultswithsystemiclupuserythematosus AT golamsarowar letterinreplyindirecttreatmentcomparisonofanifrolumabefficacyversusbelimumabinadultswithsystemiclupuserythematosus AT steenkampjason letterinreplyindirecttreatmentcomparisonofanifrolumabefficacyversusbelimumabinadultswithsystemiclupuserythematosus AT wangpearl letterinreplyindirecttreatmentcomparisonofanifrolumabefficacyversusbelimumabinadultswithsystemiclupuserythematosus AT worthingtonevelyn letterinreplyindirecttreatmentcomparisonofanifrolumabefficacyversusbelimumabinadultswithsystemiclupuserythematosus AT destabarnabas letterinreplyindirecttreatmentcomparisonofanifrolumabefficacyversusbelimumabinadultswithsystemiclupuserythematosus AT psachouliakonstantina letterinreplyindirecttreatmentcomparisonofanifrolumabefficacyversusbelimumabinadultswithsystemiclupuserythematosus AT erhardtwilma letterinreplyindirecttreatmentcomparisonofanifrolumabefficacyversusbelimumabinadultswithsystemiclupuserythematosus AT tummalaraj letterinreplyindirecttreatmentcomparisonofanifrolumabefficacyversusbelimumabinadultswithsystemiclupuserythematosus |